Varun Shah
Pulmonary Disease · Knoxville, TNNPI 1538573480
Payments from drug & device makers
Across 430 payments — averaging $148.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$35K
- Pulmonx Corporation$21K
- AstraZeneca$2K
- Siemens Medical Solutions USA, Inc.$1K
- GSK$797
- Amgen$745
- plus $4K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 159 | $35,080 |
| Pulmonx Corporation | 54 | $20,526 |
| AstraZeneca | 45 | $1,693 |
| Siemens Medical Solutions USA, Inc. | 3 | $1,212 |
| GSK | 45 | $797 |
| Amgen | 16 | $745 |
| Boehringer Ingelheim | 17 | $503 |
| Mylan Specialty L.p. | 6 | $414 |
| Galvanize Therapeutics, Inc | 4 | $381 |
| Insmed, Inc. | 9 | $259 |
| Sanofi | 10 | $231 |
| Regeneron Healthcare Solutions, Inc. | 9 | $187 |
| Medtronic | 2 | $183 |
| Serpex Medical Inc | 1 | $172 |
| Grifols USA, LLC | 7 | $158 |
| Actelion Pharmaceuticals US, Inc. | 4 | $124 |
| Baxter Healthcare | 6 | $109 |
| UCB, Inc. | 1 | $100 |
| Fujifilm Healthcare Americas Corporation | 1 | $95 |
| Merck | 3 | $94 |
| Verona Pharma, Inc. | 4 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $77 |
| Merit Medical Systems Inc | 1 | $77 |
| Viatris Specialty LLC | 2 | $76 |
| Olympus America Inc. | 2 | $62 |
| Philips North America LLC | 3 | $50 |
| United Therapeutics Corporation | 2 | $48 |
| La Jolla Pharmaceutical Company | 2 | $45 |
| Johnson & Johnson(2 entities) | 2 | $40 |
| Inogen, Inc. | 2 | $36 |
| Mallinckrodt Hospital Products Inc. | 1 | $28 |
| CMP Pharma, Inc. | 1 | $27 |
| ANI Pharmaceuticals, Inc. | 1 | $21 |
| Shionogi Inc | 1 | $20 |
| Electromed, Inc. | 1 | $14 |
How this compares
$63,773 in reported general payments places this provider in the 90th percentile of 339 pulmonary disease providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Knoxville
- John SwisherKnoxville$2.3M
- Eric WeaverKnoxville$492K
- Rajiv DhandKnoxville$426K
- John CallisonKnoxville$324K
- John PrinceKnoxville$117K
- Isaac BineyKnoxville$73K
- Benjamin BevillKnoxville$31K
- Bashar BargotyKnoxville$28K
- Zulma SwankKnoxville$24K
- Shannon ByrdKnoxville$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.